Clinical Trials Browser

OTHER × Alemtuzumab × Other neoplasm × Clear all

NCT02701517 2017-12-29

Cyclosporine Plus Methotrexate or Alemtuzumab

Phase 2 Terminated

LymphoidOther neoplasm

Unrecognized Condition: Mature B or T-cell Neoplasm